Figure 3
From: Prognostic value of decreased expression of RBM4 in human gastric cancer
Correlation between RBM4 expression and clinicopathologic parameters and patients survival in human gastric cancer.
(A) Low or no RBM4 expression correlates with a poorer overall cumulative survival for 605 gastric cancer patients (P < 0.001, log-rank test). (B) Low or no RBM4 expression was found to be correlated with a poorer disease-free survival for 605 gastric cancer patients (P < 0.001, log-rank test). (C) TNM III + IV correlates with a poorer overall cumulative survival for 605 gastric cancer patients (P < 0.001, log-rank test).
